Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2016

29.12.2015 | Breast Oncology

Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study

verfasst von: Kaveh Borhani-Khomani, MS, Maj-Lis Møller Talman, MD, Niels Kroman, MD, DMSc, Tove Filtenborg Tvedskov, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the recurrence rate of benign and borderline phyllodes tumors (PTs) of the breast, the association between the size of resection margin and risk of recurrence and the risk of progression of histological grading at recurrence.

Methods

Nationwide retrospective study on Danish women aged 18 years or older, operated from 1999 to 2014, with resected benign or borderline PTs. Information on age, size of primary tumor and recurrence, histological grade, surgical treatment, margin size, and local recurrence were collected from the national Danish Pathology Register.

Results

A total of 479 cases were identified; 354 benign (74 %), 89 borderline (19 %), 6 uncertain histological grading (1.2 %), and 30 possibly PT (6 %). The mean age at presentation was 45.6 years (range 18–85), the mean tumor size was 3.5 cm (range 0.5–21), and the mean follow-up time was 98 months (range 1.1–192). We identified 30 local recurrences, i.e., a recurrence rate of 6.3 %. Twenty-three recurrences had similar or lower histological grading than the primary tumor, one primary benign PT recurred as a tumor with unclear diagnosis, and one primary borderline PT recurred as malignant. The number of recurrences was too low, and the information on the size of the closest resection margin was too sparse to estimate an adequate margin size for excision of nonmalignant PTs.

Conclusions

The recurrence rate of PTs was considerably lower than previously stated in literature. No apparent pattern of progression in histological grading was found. The results do not justify wide excision margins of nonmalignant phyllodes tumors of the breast.
Literatur
1.
Zurück zum Zitat Kim S, Kim JY, Kim do H, Jung WH, Koo JS. Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat. 2013;141(3):353–63.CrossRefPubMed Kim S, Kim JY, Kim do H, Jung WH, Koo JS. Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat. 2013;141(3):353–63.CrossRefPubMed
2.
Zurück zum Zitat Karim RZ, Gerega SK, Yang YH, Spillane A, Carmalt H, Scolyer RA, Lee CS. Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast. 2009;18(3):165–70.CrossRefPubMed Karim RZ, Gerega SK, Yang YH, Spillane A, Carmalt H, Scolyer RA, Lee CS. Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast. 2009;18(3):165–70.CrossRefPubMed
3.
Zurück zum Zitat Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO classification of Tumours of the Breast, 4th edn. IARC Press, Lyon, 2012:143–7. Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO classification of Tumours of the Breast, 4th edn. IARC Press, Lyon, 2012:143–7.
4.
Zurück zum Zitat Tan PH, Jayabaskar T, Chuah KL, et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol. 2005;123(4):529–40.CrossRefPubMed Tan PH, Jayabaskar T, Chuah KL, et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol. 2005;123(4):529–40.CrossRefPubMed
5.
Zurück zum Zitat Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77(5):910–6.CrossRefPubMed Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77(5):910–6.CrossRefPubMed
6.
Zurück zum Zitat Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL, Liu TP. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91(3):185–94.CrossRefPubMed Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL, Liu TP. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91(3):185–94.CrossRefPubMed
7.
Zurück zum Zitat Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R, Teramoto N. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol. 2007;37(10):730–6.CrossRefPubMed Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R, Teramoto N. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol. 2007;37(10):730–6.CrossRefPubMed
8.
Zurück zum Zitat Barth RJ Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57(3):291–5.CrossRefPubMed Barth RJ Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57(3):291–5.CrossRefPubMed
10.
Zurück zum Zitat McCarthy E, Kavanagh J, O’Donoghue Y, McCormack E, D’Arcy C, O’Keeffe SA. Phyllodes tumours of the breast: radiological presentation, management and follow-up. Br J Radiol. 2014; 87: 20140239.CrossRefPubMedPubMedCentral McCarthy E, Kavanagh J, O’Donoghue Y, McCormack E, D’Arcy C, O’Keeffe SA. Phyllodes tumours of the breast: radiological presentation, management and follow-up. Br J Radiol. 2014; 87: 20140239.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Yom CK, Han W, Kim SW, Park SY, Park IA, Noh DY. Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol. 2015 doi: 10.1245/s10434-015-4395-5.PubMed Yom CK, Han W, Kim SW, Park SY, Park IA, Noh DY. Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol. 2015 doi: 10.​1245/​s10434-015-4395-5.PubMed
12.
Zurück zum Zitat Tan EY, Tan PH, Yong WS, Wong HB, Ho GH, Yeo AW, Wong CY. Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg. 2006;76(6):476–80.CrossRefPubMed Tan EY, Tan PH, Yong WS, Wong HB, Ho GH, Yeo AW, Wong CY. Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg. 2006;76(6):476–80.CrossRefPubMed
13.
Zurück zum Zitat Hajdu SI, Espinosa MH, Robbins GF. Recurrent cystosarcoma phyllodes a clinicopathologic study of 32 cases. Cancer. 1976;38(3):1402–6.CrossRefPubMed Hajdu SI, Espinosa MH, Robbins GF. Recurrent cystosarcoma phyllodes a clinicopathologic study of 32 cases. Cancer. 1976;38(3):1402–6.CrossRefPubMed
14.
Zurück zum Zitat Tan PH, Thike AA, Tan WJ, et al. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012;65(1):69–76.CrossRefPubMed Tan PH, Thike AA, Tan WJ, et al. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012;65(1):69–76.CrossRefPubMed
15.
Zurück zum Zitat Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39(7 Suppl):72–4.CrossRefPubMed Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39(7 Suppl):72–4.CrossRefPubMed
16.
17.
Zurück zum Zitat Akcakaya A, Koc B, Erozgen F, et al. Unpredictable behavior of breast phyllodes tumors. Eur Rev Med Pharmacol Sci. 2014;18(18):2655–61.PubMed Akcakaya A, Koc B, Erozgen F, et al. Unpredictable behavior of breast phyllodes tumors. Eur Rev Med Pharmacol Sci. 2014;18(18):2655–61.PubMed
18.
Zurück zum Zitat Spitaleri G, Toesca A, Botteri E, Bottiglieri L, et al. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol. 2013;88(2):427–36.CrossRefPubMed Spitaleri G, Toesca A, Botteri E, Bottiglieri L, et al. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol. 2013;88(2):427–36.CrossRefPubMed
19.
Zurück zum Zitat Christiansen P, Vejborg I, Kroman N, Holten I, Garne JP, Vedsted P, Moller S, Lynge E. Position paper: breast cancer screening, diagnosis, and treatment in Denmark. Acta Oncol. 2014; 53.4: 433–444.CrossRefPubMed Christiansen P, Vejborg I, Kroman N, Holten I, Garne JP, Vedsted P, Moller S, Lynge E. Position paper: breast cancer screening, diagnosis, and treatment in Denmark. Acta Oncol. 2014; 53.4: 433–444.CrossRefPubMed
20.
Zurück zum Zitat Nio Y, Iguchi C, Tsuboi K, Maruyama R. Ductal carcinoma in situ arising within a benign phyllodes tumor: a case report with a review of the literature. Oncol Lett. 2011;2(2):223–8.CrossRefPubMedPubMedCentral Nio Y, Iguchi C, Tsuboi K, Maruyama R. Ductal carcinoma in situ arising within a benign phyllodes tumor: a case report with a review of the literature. Oncol Lett. 2011;2(2):223–8.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Jara-Lazaro AR, Tan PH. Molecular pathogenesis of progression and recurrence in breast phyllodes tumors. Am J Transl Res. 2009;1(1):23–34.PubMedPubMedCentral Jara-Lazaro AR, Tan PH. Molecular pathogenesis of progression and recurrence in breast phyllodes tumors. Am J Transl Res. 2009;1(1):23–34.PubMedPubMedCentral
22.
Zurück zum Zitat Stebbing JF, Nash AG. Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre. Ann R Coll Surg Engl. 1995;77(3):181–4.PubMedPubMedCentral Stebbing JF, Nash AG. Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre. Ann R Coll Surg Engl. 1995;77(3):181–4.PubMedPubMedCentral
24.
Zurück zum Zitat Barrio AV, Clark BD, Goldberg JI, et al. Clinicopathologic features and long term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14(10):2961–70.CrossRefPubMed Barrio AV, Clark BD, Goldberg JI, et al. Clinicopathologic features and long term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14(10):2961–70.CrossRefPubMed
25.
Zurück zum Zitat Wei J, Tan YT, Cai YC, et al. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chin J Cancer. 2014;33(10):492–500.PubMedPubMedCentral Wei J, Tan YT, Cai YC, et al. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chin J Cancer. 2014;33(10):492–500.PubMedPubMedCentral
26.
Zurück zum Zitat Lin CC, Chang HW, Lin CY, Chiu CF, Yeh SP. The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan. Int J Clin Oncol. 2013;18(4):614–20.CrossRefPubMed Lin CC, Chang HW, Lin CY, Chiu CF, Yeh SP. The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan. Int J Clin Oncol. 2013;18(4):614–20.CrossRefPubMed
27.
Zurück zum Zitat Vilela MH, de Almeida FM, de Paula GM, Ribeiro NB, Cirqueira MB, Silva AL, Moreira MA. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast. Int J Surg Pathol. 2014;22(6):485–91.CrossRefPubMed Vilela MH, de Almeida FM, de Paula GM, Ribeiro NB, Cirqueira MB, Silva AL, Moreira MA. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast. Int J Surg Pathol. 2014;22(6):485–91.CrossRefPubMed
28.
Zurück zum Zitat Kucuk U, Bayol U, Pala EE, Cumurcu S. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast. Indian J Pathol Microbiol. 2013;56(2):129–34.CrossRefPubMed Kucuk U, Bayol U, Pala EE, Cumurcu S. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast. Indian J Pathol Microbiol. 2013;56(2):129–34.CrossRefPubMed
29.
Zurück zum Zitat Khazai L, Middleton LP, Goktepe N, Liu BT, Sahin AA. Breast pathology second review identifies clinically significant discrepancies in over 10% of patients. J Surg Oncol. 2015;111(2):192–7.CrossRefPubMed Khazai L, Middleton LP, Goktepe N, Liu BT, Sahin AA. Breast pathology second review identifies clinically significant discrepancies in over 10% of patients. J Surg Oncol. 2015;111(2):192–7.CrossRefPubMed
30.
Zurück zum Zitat Lawton TJ, Acs G, Argani P, et al. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors. Int J Surg Pathol. 2014;22(8):695–8.CrossRefPubMedPubMedCentral Lawton TJ, Acs G, Argani P, et al. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors. Int J Surg Pathol. 2014;22(8):695–8.CrossRefPubMedPubMedCentral
Metadaten
Titel
Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study
verfasst von
Kaveh Borhani-Khomani, MS
Maj-Lis Møller Talman, MD
Niels Kroman, MD, DMSc
Tove Filtenborg Tvedskov, MD, PhD
Publikationsdatum
29.12.2015
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-5041-y

Weitere Artikel der Ausgabe 5/2016

Annals of Surgical Oncology 5/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.